Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Patent
1989-03-13
1991-01-15
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
534562, C07C24520, A61K 31655
Patent
active
049854160
ABSTRACT:
Complexes having the structure ##STR1## in which R, R.sub.1, R.sub.2, R.sub.3 represent lower alkyl groups are cytotoxic to tumor cells in mammals and enhance the killing effect of radiation and heat.
REFERENCES:
patent: 1889298 (1932-11-01), Schnitzpahn I
Richmond et al., Radiation Research, vol. 71, 447-460, (1977).
Bernal et al., Science, vol. 222, 169-172, (1983).
Teicher et al. I, Int. J. Rad. Onc. Biol. Phys., vol. 11, 937-941, (1985).
Teicher et al. II, Int. J. Rad. Onc. Biol. Phys., vol. 13, 1217-1224, (1987).
Teicher et al. III, Rad. Res., vol. 109, 58-67, (1987).
Teicher et al. IV, Biochem. Pharmacol., vol. 35, 3365-3369, (1986).
Dana Farber Cancer Institute, Inc.
Higel Floyd D.
LandOfFree
Platinum complexes of azodiazonium dyes as anti-tumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platinum complexes of azodiazonium dyes as anti-tumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platinum complexes of azodiazonium dyes as anti-tumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55379